DENTSPLY SIRONA Inc. (XRAY): Price and Financial Metrics
DENTSPLY SIRONA Inc. (XRAY)
Today's Latest Price: $44.60 USD
Updated Oct 19 5:20pm
Add XRAY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
XRAY Stock Summary
- DENTSPLY SIRONA Inc's market capitalization of $9,980,915,187 is ahead of 84.32% of US-listed equities.
- With a one year PEG ratio of 233.16, DENTSPLY SIRONA Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 85.45% of US stocks.
- DENTSPLY SIRONA Inc's stock had its IPO on April 25, 1991, making it an older stock than 83.56% of US equities in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to DENTSPLY SIRONA Inc are BRO, IVZ, WRB, ESE, and BEN.
- XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to www.dentsplysirona.com.
XRAY Stock Price Chart Interactive Chart >
XRAY Price/Volume Stats
| Current price | $44.60 | 52-week high | $60.87 |
| Prev. close | $45.68 | 52-week low | $31.58 |
| Day low | $44.40 | Volume | 512,200 |
| Day high | $45.88 | Avg. volume | 1,954,817 |
| 50-day MA | $44.54 | Dividend yield | 0.88% |
| 200-day MA | $45.62 | Market Cap | 9.74B |
DENTSPLY SIRONA Inc. (XRAY) Company Bio
DENTSPLY International designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company was founded in 1899 and is based in York, Pennsylvania.
XRAY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $44.60 | $18.92 | -59% |
Below please find a table outlining a discounted cash flow forecast for XRAY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that DENTSPLY SIRONA Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of DENTSPLY SIRONA Inc, consider:
- In the past 5.46 years, DENTSPLY SIRONA Inc has a compound free cash flow growth rate of 0.03%; that's higher than merely 22.75% of free cash flow generating stocks in the Healthcare sector.
- DENTSPLY SIRONA Inc's effective tax rate, as measured by taxes paid relative to net income, is at 62 -- greater than 95.52% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -59% |
| 1% | -59% |
| 2% | -59% |
| 3% | -58% |
| 4% | -58% |
| 5% | -57% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as XRAY, try IONS, RMD, JNJ, PKI, and ILMN.
Loading social stream, please wait...